Director Karen Ling adds Bausch & Lomb (BLCO) shares and gets 4,000 RSUs

Rhea-AI Filing Summary

Bausch & Lomb Corp director Karen Ling reported new purchases and awards of common shares. On February 19, 2026, she made an open-market purchase of 4,000 common shares at a weighted average price of $17.742 per share, with individual trades ranging from $17.71 to $17.75. She also acquired 4,000 matching restricted share units in connection with this purchase under the company’s matching share program, which vest in three equal annual installments starting one year after the grant date, subject to continued service.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ling Karen

(Last) (First) (Middle)

C/O

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN A6 L4K 4B4

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/19/2026		P		4,000	A	$17.742(1)	41,676	D
Common Shares, No Par Value	02/19/2026		A		4,000(2)	A	$0	45,676	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.71 to $17.75 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

2. Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).

	/s/ Debra E. Levin, attorney-in-fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Karen Ling report for Bausch & Lomb Corp (BLCO)?

Karen Ling reported buying 4,000 Bausch & Lomb common shares in the open market and receiving 4,000 matching restricted share units. Both transactions occurred on February 19, 2026, and increased her directly owned stake in the company’s common shares.

At what price did Karen Ling buy Bausch & Lomb (BLCO) shares in this Form 4 filing?

She bought 4,000 common shares at a weighted average price of $17.742 per share. The individual trades took place in a price range from $17.71 to $17.75, as disclosed in the footnotes of the Form 4 filing.

How many Bausch & Lomb (BLCO) shares does Karen Ling own after these transactions?

After the reported open-market purchase and the grant of matching restricted share units, Karen Ling’s total directly owned common shares increased to 45,676. The Form 4 shows intermediate totals following each step of the transactions reported for February 19, 2026.

What are the matching restricted share units (MRSUs) granted to Karen Ling by Bausch & Lomb (BLCO)?

The filing shows 4,000 matching restricted share units granted in connection with her open-market purchase. One-third of these MRSUs will vest on each of the first, second, and third anniversaries of the grant date, subject to her continued service with the company.

Are Karen Ling’s Bausch & Lomb (BLCO) share purchases in this Form 4 open-market transactions?

Yes. The Form 4 identifies the 4,000-share transaction with code “P,” described as a purchase in the open market or a private transaction. A weighted average price of $17.742 per share is disclosed, with a detailed price range provided in the footnotes.

Does the Bausch & Lomb (BLCO) Form 4 indicate any share sales by Karen Ling?

No share sales are reported. The summary data show one open-market purchase of 4,000 shares and one acquisition of 4,000 matching restricted share units, resulting in a net-buy direction with no disposals disclosed for the covered date.